AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Glycopyrronium Bromide in South Africa
5 products registered with SAHPRA — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CHOLSTYQ | 56/5.11/0094 | Umsebe Healthcare | active | 24 May 2027 |
| GLYCOPYRROLATE 0,2 mg/1 ml FRESENIUS | A40/5.4/0101 | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | 1 Jan 1900 |
| GLYCOPYRROLATE 0,4 mg/2 ml FRESENIUS | A40/5.4/0044 | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | 1 Jan 1900 |
| ROBINUL 1 ml INJECTABLE | J/5.4/50 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| ROBINUL 2 ml INJECTABLE | W/5.4/129 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
Glycopyrronium Bromide — SAHPRA Registration Details
SAHPRA (South Africa) has 5 registered products containing Glycopyrronium Bromide, of which 5 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Glycopyrronium Bromide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.